Tracheal allograft stable after immunosuppressive therapy

April 17, 2014
Tracheal allograft stable after immunosuppressive therapy

(HealthDay)—A composite-tissue tracheal allograft appears to have retained its structural integrity after the withdrawal of immunosuppressive therapy, according to a letter to the editor published in the April 17 issue of the New England Journal of Medicine.

Pierre R. Delaere, M.D., Ph.D., from the University Hospital Leuven in Belgium, and colleagues have performed tracheal allografts in five (four patients with long-segment stenosis and one patient with a low-grade chondrosarcoma). In the patient with recurrent tracheal chondrosarcoma, rejection was visualized in situ following withdrawal of . The authors report on the healing mechanisms responsible for the survival of the allograft after immunologic rejection of the donor tissue.

The researchers write that an allograft was placed in this patient's forearm for three months, during which time, the donor respiratory epithelium was revascularized and an autograft of recipient buccal mucosa was introduced in the midportion of the allograft. Following resections of the patient's tracheal tumor, the allograft was moved to its correct anatomical position with an intact blood supply.

"Two years after transplantation, the allograft was stable and functional, and the patient reported that he was satisfied with the result," the authors write.

Explore further: Leading surgeons warn against media hype about tracheal regeneration

More information: Full Text

Related Stories

Leading surgeons warn against media hype about tracheal regeneration

March 25, 2014
Reports of the two earliest tissue-engineered whole organ transplants using a windpipe, or trachea, created using the patient's own stem cells, were hailed as a breakthrough for regenerative medicine and widely publicized ...

Secondhand smoke results in graft rejection

February 23, 2012
A new study published in the American Journal of Transplantation reveals that cigarette smoke exposure, in a cause-effect manner, results in graft rejection that would have been prevented by certain drug treatments.

Coronary CT angiography IDs cardiac allograft vasculopathy

March 28, 2014
(HealthDay)—Noninvasive coronary computed tomography angiography (CCTA) is a reliable alternative to coronary angiography for detection of cardiac allograft vasculopathy (CAV), according to a meta-analysis published online ...

Impact of stem cell transplantation location in brain a crucial factor for cell survival

February 13, 2013
Researchers at the Johns Hopkins University in Baltimore, Md., and the Mossakowski Medical Research Centre in Warsaw, Poland, have found that nonself-donated cells (allografts) better survive implantation into the brains ...

Recommended for you

Genetic immune deficiency could hold key to severe childhood infections

July 18, 2017
A gene mutation making young children extremely vulnerable to common viruses may represent a new type of immunodeficiency, according to a University of Queensland researcher.

What are the best ways to diagnose and manage asthma?

July 18, 2017
What are the best ways to diagnose and manage asthma in adults? This can be tricky because asthma can stem from several causes and treatment often depends on what is triggering the asthma.

Large multi-ethnic study identifies many new genetic markers for lupus

July 17, 2017
Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus.

Study finds molecular explanation for struggles of obese asthmatics

July 17, 2017
A large, bouquet-shaped molecule called surfactant protein A, or SP-A, may explain why obese asthma patients have harder-to-treat symptoms than their lean and overweight counterparts, according to a new study led by scientists ...

Team identifies potential cause for lupus

July 14, 2017
Leading rheumatologist and Feinstein Institute for Medical Research Professor Betty Diamond, MD, may have identified a protein as a cause for the adverse reaction of the immune system in patients suffering from lupus. A better ...

Immunosuppression underlies resistance to anti-angiogenic therapy

July 14, 2017
A Massachusetts General Hospital (MGH) research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels. In their report ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.